Phase II and Biomarker Study of the Dual MET/VEGFR2 Inhibitor Foretinib in Patients With Papillary Renal Cell Carcinoma

CHOUEIRI, Toni K ; VAISHAMPAYAN, Ulka ; OTTESEN, Lone H ; LAUBSCHER, Kevin H ; SHERMAN, Laurie ; MCDERMOTT, David F ; HAAS, Naomi B ; FLAHERTY, Keith T ; ROSS, Robert ; EISENBERG, Peter ; MELTZER, Paul S ; MERINO, Maria J ; ROSENBERG, Jonathan E ; BOTTARO, Donald P ; MARSTON LINEHAN, W ; SRINIVASAN, Ramaprasad ; LOGAN, Theodore F ; HARZSTARK, Andrea L ; BUKOWSKI, Ronald M ; RINI, Brian I ; SRINIVAS, Sandy ; STEIN, Mark N ; ADAMS, Laurel M

Journal of clinical oncology, 2013-01, Vol.31 (2), p.181-186 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível